Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
30.06.2023 - Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on June 30, 2023. Seven individuals were hired by ...